Tom Van Maerken

2.1k total citations
38 papers, 1.1k citations indexed

About

Tom Van Maerken is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Tom Van Maerken has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 21 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Tom Van Maerken's work include Neuroblastoma Research and Treatments (22 papers), Cancer-related Molecular Pathways (11 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Tom Van Maerken is often cited by papers focused on Neuroblastoma Research and Treatments (22 papers), Cancer-related Molecular Pathways (11 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Tom Van Maerken collaborates with scholars based in Belgium, United States and Germany. Tom Van Maerken's co-authors include Jo Vandesompele, Frank Speleman, Ali Rihani, Anne De Paepe, Nurten Yigit, Jean‐Christophe Marine, Liesbeth Ferdinande, Claude Cuvelier, Joëlle Vermeulen and Irina Lambertz and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Tom Van Maerken

38 papers receiving 1.0k citations

Peers

Tom Van Maerken

ONCOL

NEURO

PFM

Luv Patel United States

Teng Ji China

Jinxiang Han China

Michelle Vincendeau Germany

Katherine Oravecz-Wilson United States

Petra Leukel Germany

Sha Tian United States

Sabine Hünten Germany

Carsten P. Ade Germany

Shinya Iida Japan

Luv Patel United States

Tom Van Maerken

459 ×0.7

221 ×0.5

ONCOL

68 ×0.2

NEURO

77 ×0.3

68 ×0.6

PFM

Citations per year, relative to Tom Van Maerken Tom Van Maerken (= 1×) peers Luv Patel

Countries citing papers authored by Tom Van Maerken

Since Specialization

Citations

This map shows the geographic impact of Tom Van Maerken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Van Maerken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Van Maerken more than expected).

Fields of papers citing papers by Tom Van Maerken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Van Maerken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Van Maerken. The network helps show where Tom Van Maerken may publish in the future.

Co-authorship network of co-authors of Tom Van Maerken

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Van Maerken. A scholar is included among the top collaborators of Tom Van Maerken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Van Maerken. Tom Van Maerken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anckaert, Jasper, Anneleen Decock, Kaat Durinck, et al.. (2023). Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

Goethem, Alan Van, Nurten Yigit, Celine Everaert, et al.. (2023). Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation. NAR Cancer. 5(1). zcad002–zcad002. 3 indexed citations

Maerken, Tom Van, Liselotte Coorevits, Stefaan Bouchez, et al.. (2019). A recurrent and transesophageal echocardiography–associated outbreak of extended-spectrum β-lactamase–producing Enterobacter cloacae complex in cardiac surgery patients. Antimicrobial Resistance and Infection Control. 8(1). 152–152. 6 indexed citations

Oyaert, Matthijs, et al.. (2018). Analytical and pre-analytical performance characteristics of a novel cartridge-type blood gas analyzer for point-of-care and laboratory testing. Clinical Biochemistry. 53. 116–126. 15 indexed citations

Maerken, Tom Van, Anja Geerts, Xavier Verhelst, et al.. (2018). Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium. Journal of Clinical Virology. 103. 8–11. 5 indexed citations

Küsters‐Vandevelde, Heidi V.N., Vibeke Krüse, Tom Van Maerken, et al.. (2016). Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis. Experimental and Molecular Pathology. 102(1). 25–31. 10 indexed citations

Goethem, Alan Van, Nurten Yigit, Celine Everaert, et al.. (2016). Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples. Scientific Reports. 6(1). 37876–37876. 11 indexed citations

Rihani, Ali, Jo Vandesompele, Frank Speleman, & Tom Van Maerken. (2015). Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma. Cancer Cell International. 15(1). 76–76. 37 indexed citations

Rihani, Ali, Alan Van Goethem, Maté Ongenaert, et al.. (2015). Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma. Scientific Reports. 5(1). 9027–9027. 31 indexed citations

10.

Ayers, Duncan, Pieter Mestdagh, Tom Van Maerken, & Jo Vandesompele. (2015). Identification of miRNAs contributing to neuroblastoma chemoresistance. Computational and Structural Biotechnology Journal. 13. 307–319. 16 indexed citations

11.

Wilde, Bram De, Tom Van Maerken, Katleen De Preter, et al.. (2014). Genetisch geïnspireerde toekomstperspectieven voor de therapie van het neuroblastoom. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

12.

Barone, Giuseppe, Deborah A. Tweddle, Jason M. Shohet, et al.. (2014). MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance. Current Drug Targets. 15(1). 114–123. 33 indexed citations

13.

Rihani, Ali, Bram De Wilde, Geneviève Laureys, et al.. (2014). CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients. PLoS ONE. 9(12). e114696–e114696. 19 indexed citations

14.

Rihani, Ali, Tom Van Maerken, Filip Pattyn, et al.. (2013). Effective Alu Repeat Based RT-Qpcr Normalization in Cancer Cell Perturbation Experiments. PLoS ONE. 8(8). e71776–e71776. 12 indexed citations

15.

Maerken, Tom Van, Ali Rihani, Alan Van Goethem, et al.. (2013). Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer. Cancer Letters. 344(2). 157–165. 36 indexed citations

16.

Maerken, Tom Van, Ali Rihani, Daniel Dreidax, et al.. (2011). Functional Analysis of the p53 Pathway in Neuroblastoma Cells Using the Small-Molecule MDM2 Antagonist Nutlin-3. Molecular Cancer Therapeutics. 10(6). 983–993. 61 indexed citations

17.

Preter, Katleen De, Sara De Brouwer, Tom Van Maerken, et al.. (2009). Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds. Clinical Cancer Research. 15(11). 3690–3696. 37 indexed citations

18.

Maerken, Tom Van, Liesbeth Ferdinande, Irina Lambertz, et al.. (2009). Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53. JNCI Journal of the National Cancer Institute. 101(22). 1562–1574. 99 indexed citations

19.

Maerken, Tom Van, et al.. (2009). Adenovirus‐mediated hPNPase^old‐35 gene transfer as a therapeutic strategy for neuroblastoma. Journal of Cellular Physiology. 219(3). 707–715. 12 indexed citations

20.

Maerken, Tom Van, Frank Speleman, Joëlle Vermeulen, et al.. (2006). Small-Molecule MDM2 Antagonists as a New Therapy Concept for Neuroblastoma. Cancer Research. 66(19). 9646–9655. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact